
Making the Case for a Digital Revolution in Market Access
As pharmaceutical companies evolve toward digital-first commercial models, U.S. market access strategies seem to be lagging in the digital revolution. Companies face many...
As pharmaceutical companies evolve toward digital-first commercial models, U.S. market access strategies seem to be lagging in the digital revolution. Companies face many...
Non-adherence to prescribed therapy can create extraordinary risks for patients. Even when provided with correct diagnoses and effective treatment plans, patients can often...
There may be no greater threat to patient outcomes than the current barriers to therapy access—especially for specialty medications.
Every day, patients need to switch to new therapies because of disease progression, side effects, affordability or other factors—and if your brand is a second- or third-, or...
It’s a problem with enormous impact for patients that has been nearly impossible to solve: Brand-eligible patients are out there, but they’ve been misdiagnosed or, even...
If you’re a life science marketer, chances are you’ve been hearing about the...
At the recent Re:Imagine Pharma Marketing virtual conference, I was excited to present on how brand...
In our first two blog posts on challenges related to multiple sclerosis (MS) treatment, we addressed the need to build awareness...
In our initial blog post on challenges related to multiple sclerosis (MS) treatment, we discussed the first barrier, which is...
When it comes to multiple sclerosis (MS), there are multiple challenges that can deter patients from receiving the care they...
As the coronavirus (COVID-19) spread across the nation, greatly impacting people’s health and lives, trustworthy and relevant health information from a reliable source became...